4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035690
Director sold 1,485 shares at $51.65 ($76,700)
- Director acquired 3,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. Director | 2023-06-07 | Grant or award | +3,860 | 11,055 | D: show line 1 in the form | ||
| Sanders Corazon (Corsee) D. Director | 2023-06-08 | Sale | −1,485 | $51.65 | $76,700 | 9,570 | D: show line 2 in the form |
| Open-market sales · 1,485 sh · avg $51.65 · $76,700 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. Director | 2023-06-07 | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | D: show line 3 in the form |
Loading xslF345X04/doc4.xml…